Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 and up

COMBO oropharyngeal airway during sedated ERCP

Official title: COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients

Run by Zhejiang University · NCT07012772 · Data updated 2026-11-12

This test will see if the COMBO Endoscopy Oropharyngeal Airway reduces episodes of low oxygen (hypoxia) in adults undergoing ERCP with propofol sedation.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorZhejiang University
Academic / other
Locations2 sites (Hangzhou, Zhejiang and 1 other locations)
StatusRecruiting
StartedJune 12, 2025
Main results expectedSeptember 30, 2025
Study endsDecember 31, 2025
Registry record updatedJune 24, 2025
Trial IDNCT07012772 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 or older with ASA physical status I–III who are scheduled for ERCP under propofol sedation for procedures expected to last 45 minutes or less and who can give informed consent.

Probably not a fit

Patients with COPD or other chronic pulmonary disease requiring oxygen, severe cardiac or renal failure, coagulopathy, active upper respiratory infection, pregnancy, or anatomical issues preventing airway insertion are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 interventional trial enrolls adults (ASA I–III) scheduled for ERCP under propofol sedation and uses the COMBO Endoscopy Oropharyngeal Airway, a device combining capnography, a bite block, oxygen delivery, and an oropharyngeal airway, during the procedure. The main outcome is the incidence of hypoxia during procedures expected to last 45 minutes or less. Key exclusions include significant pulmonary disease, severe cardiac or renal dysfunction, coagulopathy, active upper airway infection, pregnancy, and airway anatomy that prevents device use. The study is conducted at the First Affiliated Hospital, Zhejiang University School of Medicine in Hangzhou, China.

Why it matters

Potential benefit: If successful, the device could lower the risk of low-oxygen events during sedated ERCP and improve patient safety.

How similar studies have gone: Elements such as capnography monitoring and airway adjuncts have reduced respiratory events during procedural sedation, but the COMBO integrated airway device is relatively new and has limited published trial data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years;
* The ASA classification ranges from I to III.
* Patients have signed the informed consent form.
* Patients scheduled to undergo sedated ERCP examination;
* The estimated duration of the procedure does not exceed 45 minutes.

Exclusion Criteria:

1. Patients with coagulation disorders, tendency for oral/nasal bleeding, mucosal injury/occupying lesions, or difficult oropharyngeal airway insertion making airway management unfeasible;
2. Severe cardiac dysfunction (\<4 METs);
3. Severe renal insufficiency (requiring preoperative dialysis);
4. Child-Pugh class C;
5. Diagnosed chronic obstructive pulmonary disease (COPD) or other acute/chronic pulmonary diseases requiring long-term/intermittent oxygen therapy;
6. Increased intracranial pressure;
7. Upper respiratory tract infections (oral/nasal/pharyngeal);
8. Fever (core temperature \>37.5°C);
9. Confirmed pregnancy or current breastfeeding;
10. Allergy to sedatives (e.g., propofol) or medical adhesives;
11. Emergency procedures;
12. Multiple trauma injuries;
13. Peripheral oxygen saturation (SpO2) levels below 95% while breathing room air preoperatively;
14. BMI \<18.5 or \>30 kg/m²;
15. Current participation in other clinical trials;
16. Other conditions deemed ineligible by investigators.

Where it's running

  • he First Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting
  • The First Affiliated Hospital,Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.